Cannabis Science Announces Therapeutic Discovery Program initiated in the Netherlands, Executed along U.S. Guidelines for Regulatory Submission

Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization

Medical Marijuana News – THCbiz